Skip to content
2000
Volume 1, Issue 1
  • ISSN: 2666-7967
  • E-ISSN: 2666-7975

Abstract

Objective: Our goal was to elucidate a potential molecular link between the past and current tuberculosis vaccine Bacillus Calmette-Guérin (BCG; a live attenuated strain of Mycobacterium bovis) immunization policies and COVID-19. Methods: Our sequence homology analyses have demonstrated that there is an intriguing level of sequence homology between a few of the BCG and Sars-CoV-2 proteins. Results: The data suggest that the BCG-specific memory B-cells that are preserved in BCG-vaccinated patients cross-recognize SARS-CoV-2 and that this cross-recognition may affect the virus proliferation and COVID-19 severity. Conclusion: Our results can stimulate the sharply focused follow-up experimental studies.

Loading

Article metrics loading...

/content/journals/covid/10.2174/2666796701999200629003417
2020-07-01
2025-01-10
Loading full text...

Full text loading...

/content/journals/covid/10.2174/2666796701999200629003417
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test